Carregant...
A Case Report on Varenicline Induced Delirium in an Alcohol and Nicotine Dependent Patient
Varenicline is a smoking cessation agent. Varenicline acts as a partial agonist of α(4)β(2) neuronal nicotinic acetylcholine receptor and prevents nicotine binding to the same. It also causes dopamine (DA) stimulation that decreases craving and symptoms of dependence. A 40-year-old male diagnosed wi...
Guardat en:
| Publicat a: | Indian J Psychol Med |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4649805/ https://ncbi.nlm.nih.gov/pubmed/26664090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7176.162926 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|